Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) fair value: what the stock is really worth
As of Nov 13, 2026: fair value (intrinsic value) of Jagsonpal Pharmaceuticals Limited stock ₹86.22, price ₹216, that is 60.1% below the price, quality 64 out of 100. Rating: strongly overvalued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Jagsonpal Pharmaceuticals Limited
JAGSNPHARM · NSEFar too expensive (fair value 60% below the price), but solid company and rising price: meets 2 of 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 14, 2026.
How to read this chart
60‑month range ₹50.35 – ₹297.89 · fair‑value band ₹56.88 – ₹121.20 · the ₹216.15 price screens above the ₹86.22 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). 1 fiscal year is left out: there the valuation rested on only a fraction of the usual models. As of Nov 14, 2026.
Every Wednesday you see whether Jagsonpal Pharmaceuticals is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Jagsonpal Pharmaceuticals Limited engages in the manufacturing, selling, and trading of pharmaceutical products and active pharmaceutical ingredients in India and internationally.
Show moreShow less
It offers pharmaceutical formulations and products in the areas of gynaecology, orthopaedics, dermatology, and paediatrics. The company provides drugs in the form of tablets, softgels, injections, capsules, and syrups.
Jagsonpal Pharmaceuticals Limited was incorporated in 1978 and is based in Gurugram, India.
Stock analysis
Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) currently trades at ₹216.15, while our model-based Fair Value estimate is ₹86.22, 60% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of ₹125.22 per share, and 0 of the 26 models we run sit above the ₹216.15 price.
Bear case: the Asset-Based group reads lowest at ₹15.53, and 26 of the 26 models stay below the price. Data coverage for this calculation is high.
Scenario range: ₹56.88 (bear) to ₹121.20 (bull), the price of ₹216.15 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 64/100 (solid quality), in the Healthcare sector.
Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Jagsonpal Pharmaceuticals Limited reported revenue of ₹2.9B in FY2026 versus ₹2.2B in FY2022, a compound +7.2%/yr. Reported net income was ₹431M in FY2026, compounding +22.9%/yr from FY2022.
Key figures
Market cap ₹14.8B (≈ $157M) Micro · P/E ratio 32.2 · P/S ratio 5.02 · EPS (TTM) ₹6.71 · Dividend yield 1.9% · Net margin 15.5% · Return on equity 16.7% · Return on assets (EBIT) 14.6% (5-year average).
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 70 out of 100 (low confidence).
What moves the price
The share trades about 12% below its 52-week high and 36% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −27% fair-value upside, at −60%, JAGSNPHARM screens richer than that median.
Fair Value models
All 26 models by family
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
Growth Forecast
JAGSNPHARM screens overvalued: fair value 60% below the price. Compare with Merck KGaA →
Compare Jagsonpal Pharmaceuticals Limited with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Drug Manufacturers - Specialty & Generic · 605 stocks
Valuation Multiplesvs Drug Manufacturers - Specialty & Generic median · lower = cheaper
Strength profile in five axes (Snowflake)
VALUE 0: the price sits above our fair-value range.
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Return on assets by industry
- Fair value gap by industry
- Stock screener with 62 metrics
- Undervalued stocks: Indian Stocks
- Valuation of the India market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Drug Manufacturers - Specialty & Generic stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Zoetis Inc ZTS | $83.82 | $113.53 | +35% | vs JAGSNPHARM |
| Jiangsu Hengrui Pharmaceuticals Co 600276 | ¥48.07 | ¥53.04 | +10% | vs JAGSNPHARM |
| Sun Pharmaceutical Industries Limited SUNPHARMA | ₹1,880 | ₹1,983 | +5% | vs JAGSNPHARM |
| Haleon plc HLN | $9.17 | $8.47 | −8% | vs JAGSNPHARM |
| Merck KGaA MRK | €149.60 | €108.83 | −27% | vs JAGSNPHARM |
| Galderma Group GALD | CHF 191.40 | CHF 112.30 | −41% | vs JAGSNPHARM |
| Takeda Pharmaceutical Company TAK | $21.43 | $11.20 | −48% | vs JAGSNPHARM |
| Sandoz Group SDZ | CHF 84.60 | CHF 40.54 | −52% | vs JAGSNPHARM |
| Teva Pharmaceutical Industries Limited TEVA | $44.50 | $20.74 | −53% | vs JAGSNPHARM |
| Divi's Laboratories Limited DIVISLAB | ₹11,442 | ₹1,567 | −86% | vs JAGSNPHARM |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) overvalued or undervalued?
What is the fair value of JAGSNPHARM?
What is the quality score of JAGSNPHARM?
What is the price target for Jagsonpal Pharmaceuticals Limited (JAGSNPHARM)?
What is the Jagsonpal Pharmaceuticals Limited stock forecast for 2026?
What is the revenue of Jagsonpal Pharmaceuticals Limited (JAGSNPHARM)?
Does Jagsonpal Pharmaceuticals Limited pay a dividend?
How much is the dividend of Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) and when is the ex-dividend date?
What growth is priced into Jagsonpal Pharmaceuticals Limited (JAGSNPHARM)?
What discount rate (WACC) does the fair value of JAGSNPHARM use?
What is a reverse DCF?
How much growth has Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) delivered so far?
How fast is the sector of Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) growing?
What is the free cash flow yield of Jagsonpal Pharmaceuticals Limited (JAGSNPHARM)?
What is the intrinsic value of Jagsonpal Pharmaceuticals Limited (JAGSNPHARM)?
Is Jagsonpal Pharmaceuticals Limited stock overvalued or undervalued in 2026?
Is fair value the same as the market price of JAGSNPHARM?
How much is Jagsonpal Pharmaceuticals Limited worth?
What do the bullish and bearish scenarios say about JAGSNPHARM?
What is the P/E ratio of JAGSNPHARM?
How solid is the balance sheet of Jagsonpal Pharmaceuticals Limited (JAGSNPHARM)?
How far is JAGSNPHARM from its 52-week high?
Which stocks are comparable to Jagsonpal Pharmaceuticals Limited?
Is Jagsonpal Pharmaceuticals Limited stock attractive at the current price?
How is the fair value of JAGSNPHARM calculated?
Is it still worth investing in stocks now?
What is the share price of Jagsonpal Pharmaceuticals Limited (JAGSNPHARM)?
What should I pay attention to with Jagsonpal Pharmaceuticals Limited right now?
Where does the earnings growth of Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) come from?
Key figures of Jagsonpal Pharmaceuticals Limited
How large is the market capitalisation of Jagsonpal Pharmaceuticals Limited (JAGSNPHARM)?
What is the P/S ratio of Jagsonpal Pharmaceuticals Limited (JAGSNPHARM)?
What are the earnings per share of Jagsonpal Pharmaceuticals Limited (JAGSNPHARM)?
What is the dividend yield of Jagsonpal Pharmaceuticals Limited (JAGSNPHARM)?
What is the net margin of Jagsonpal Pharmaceuticals Limited (JAGSNPHARM)?
What is the return on equity of Jagsonpal Pharmaceuticals Limited (JAGSNPHARM)?
What is the EBIT return on assets of Jagsonpal Pharmaceuticals Limited (JAGSNPHARM)?
What is the operating margin of Jagsonpal Pharmaceuticals Limited (JAGSNPHARM)?
How fast is revenue growing at Jagsonpal Pharmaceuticals Limited (JAGSNPHARM)?
How fast are earnings growing at Jagsonpal Pharmaceuticals Limited (JAGSNPHARM)?
How much net cash does Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) hold?
Watch Jagsonpal Pharmaceuticals Limited in the live analysis
One click puts Jagsonpal Pharmaceuticals Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.